Adimmune (4142.TW) Earnings Analysis
Adimmune (4142.TW) next reports earnings on 2026-08-07. Last quarter (2026-03-11) it beat with EPS 0.52 TWD vs 0.21 TWD est (+147.6%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E -35.52.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4142.TW next report earnings?
| Next earnings date | 2026-08-07 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
4142.TW earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-11 | 0.52 TWD | 0.21 TWD | +147.6% | Beat |
| 2025-11-12 | -0.04 TWD | 0.59 TWD | -106.8% | Miss |
| 2025-03-12 | -0.12 TWD | 0.21 TWD | -157.1% | Miss |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
4142.TW valuation and analyst view
| Trailing P/E | -35.52 |
|---|---|
| Trailing EPS | -0.6929 TWD |
| Price / book | 1.51 |
| Dividend yield | 0.00% |
| Market cap | 7.19B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Adimmune (4142.TW)'s next earnings date?
Adimmune is next scheduled to report on 2026-08-07.
Did 4142.TW beat earnings last quarter?
In its 2026-03-11 report, 4142.TW posted EPS of 0.52 TWD versus a 0.21 TWD estimate — a beat of 147.6%.
What is 4142.TW's earnings track record?
Over the last 3 reported quarters with consensus data, 4142.TW beat estimates 1 times (33%).
What is 4142.TW's current P/E ratio and EPS?
4142.TW trades at a trailing P/E of -35.52 on trailing EPS of -0.6929026258101862 TWD.
What do analysts rate 4142.TW?
4142.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.